Is there clinical evidence for sensor-based Glucose Monitoring to the front lines of diabetes practice compared with self-monitoring blood glucose (SMBG) within the patient group with Type 1 Diabetes?

Petersson, S. J. (Underviser)

Aktivitet: Andre aktivitetstyperAndet


New technology in the treatment of Type 1 diabetes includes continuous glucose monitors (CGM) that measure interstitial glucose, which correlates well with capillary blood glucose. This CAT focus on the beneficial effects of using the newly developed devices for continuous glucose monitoring on HbA1c levels and hypoglycemia in Type 1 diabetes.
Periode2 mar. 2020